Literature DB >> 16448697

Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines.

Jordi Camps1, Itziar Salaverria, Maria J Garcia, Esther Prat, Sílvia Beà, Jessica C Pole, Lluis Hernández, Javier Del Rey, Juan Cruz Cigudosa, Marta Bernués, Carlos Caldas, Dolors Colomer, Rosa Miró, Elías Campo.   

Abstract

Mantle-cell lymphoma (MCL) is genetically characterized by 11q13 chromosomal translocations involving the CCND1 gene. We have characterized five MCL cell lines, JVM-2, GRANTA-519, REC-1, JEKO-1, and NCEB-1, combining metaphase and array comparative genomic hybridization, multicolor-FISH, and molecular analysis. Our results revealed common gained regions at 2p14, 9q31.2-qter, 11q13.1-q21, 13q14-q21.2, 13q34-qter and 18q21.1-q22.1, and losses at 1p21.2-p31.1, 2p11.2, 8p21.2-pter, 9p21.3-pter, 11q23.3-qter, 17p11.2-pter, and 17q21.2-q22.2. All cell lines except JVM-2, displayed moderate or high numerical chromosome instability. In addition, an ongoing level of chromosome rearrangements was observed in REC-1. Surprisingly, NCEB-1 carried several stable mouse chromosomes and showed expression of both human and murine bcl-2 protein. Our findings indicate that these cell lines represent three patterns of chromosome evolution in MCL and may be useful to understand the pathogenesis of this neoplasm.

Entities:  

Mesh:

Year:  2006        PMID: 16448697     DOI: 10.1016/j.leukres.2005.11.013

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  14 in total

1.  Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma.

Authors:  Martina Rudelius; Stefania Pittaluga; Satoshi Nishizuka; Trinh H-T Pham; Falko Fend; Elaine S Jaffe; Leticia Quintanilla-Martinez; Mark Raffeld
Journal:  Blood       Date:  2006-04-27       Impact factor: 22.113

2.  Interleukin 22 signaling promotes cell growth in mantle cell lymphoma.

Authors:  Pascal Gelebart; Zoulika Zak; Jennifer Dien-Bard; Mona Anand; Raymond Lai
Journal:  Transl Oncol       Date:  2011-02-01       Impact factor: 4.243

3.  Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma.

Authors:  Afak Rasheed Salman Zaidi; Sadie Dresman; Charlotte Burt; Simon Rule; Lynn McCallum
Journal:  J Cell Commun Signal       Date:  2018-11-21       Impact factor: 5.782

Review 4.  Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification.

Authors:  Raymond W Nims; Greg Sykes; Karin Cottrill; Pranvera Ikonomi; Eugene Elmore
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-10-07       Impact factor: 2.416

5.  Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.

Authors:  Russell J H Ryan; Yotam Drier; Holly Whitton; M Joel Cotton; Jasleen Kaur; Robbyn Issner; Shawn Gillespie; Charles B Epstein; Valentina Nardi; Aliyah R Sohani; Ephraim P Hochberg; Bradley E Bernstein
Journal:  Cancer Discov       Date:  2015-07-30       Impact factor: 39.397

6.  Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma.

Authors:  Robert W Chen; Lynne T Bemis; Carol M Amato; Han Myint; Hung Tran; Diane K Birks; S Gail Eckhardt; William A Robinson
Journal:  Blood       Date:  2008-05-15       Impact factor: 22.113

7.  Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl-2 expression.

Authors:  Christian Bogner; Tobias Dechow; Ingo Ringshausen; Michaela Wagner; Madlen Oelsner; Gloria Lutzny; Thomas Licht; Christian Peschel; Ira Pastan; Robert J Kreitman; Thomas Decker
Journal:  Br J Haematol       Date:  2009-10-11       Impact factor: 6.998

8.  Global phosphoproteomic profiling reveals distinct signatures in B-cell non-Hodgkin lymphomas.

Authors:  Delphine Rolland; Venkatesha Basrur; Kevin Conlon; Thomas Wolfe; Damian Fermin; Alexey I Nesvizhskii; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  Am J Pathol       Date:  2014-03-22       Impact factor: 4.307

9.  Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma.

Authors:  Michael A Dengler; Charis E Teh; Rachel Thijssen; Lahiru Gangoda; Ping Lan; Marco J Herold; Daniel H Gray; Gemma L Kelly; Andrew W Roberts; Jerry M Adams
Journal:  Oncogene       Date:  2019-11-26       Impact factor: 9.867

10.  Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling.

Authors:  Chiara Pighi; Ting-Lei Gu; Irene Dalai; Stefano Barbi; Claudia Parolini; Anna Bertolaso; Serena Pedron; Alice Parisi; Jianmin Ren; Daniela Cecconi; Marco Chilosi; Fabio Menestrina; Alberto Zamò
Journal:  Cell Oncol (Dordr)       Date:  2011-03-11       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.